Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow

Miron Weinreb*, I. Suponitzky, S. Keila

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Prostaglandin E2 (PGE2) possesses significant anabolic properties when administered systemically (i.e., it increases bone formation and, consequently, bone mass). We recently characterized the effects of a 3 week administration of 6 mg/kg PGE2 into young rats and showed it increases cortical and cancellous bone mass and mechanical strength in long bones and bone density in the calvaria. We also found that a single dose of PGE2 induces the expression of early-response genes (c-fos, c-jun, and egr-1) in bone marrow cells within these two types of bone. These observations, together with findings by others of new cancellous bone formation in PGE2-treated animals, suggested that recruitment of osteoblasts from their precursors is a major mechanism of the anabolic effect of PGE2. To test this hypothesis directly, we injected PGE2 (6 mg/kg) or vehicle into 4-week-old rats for 2 weeks and then assessed the osteogenic potential of bone marrow in an ex vivo culture system. Primary and first-passage bone marrow cultures were established in the presence of β-glycerophosphate, ascorbate, and dexamethasone, and osteogenic differentiation was measured by bone nodule formation and alkaline phosphatase activity. This regimen increased bone mass expressed as femoral ash weight by 4.7% and tibial cancellous bone area by 38.3%. Nodule formation at 21 days was increased in both primary and first-passage cultures from PGE2-treated rats despite seeding of the same number of marrow cells. Alkaline phosphatase activity was elevated in both primary and first-passage cultures from PGE2-treated rats beginning 6-10 days after culture initiation. Cell proliferation was only slightly elevated in cultures from PGE2-treated rats. These data strongly suggest that in vivo administration of PGE2 induces the proliferation or differentiation of osteoprogenitor cells in bone marrow, and this effect takes a major part in its anabolic effect in vivo.

Original languageEnglish
Pages (from-to)521-526
Number of pages6
JournalBone
Volume20
Issue number6
DOIs
StatePublished - Jun 1997

Keywords

  • Alkaline phosphatase
  • Bone formation
  • Bone marrow
  • CFUf
  • Cell culture
  • Mineralized nodules
  • Osteoprogenitors
  • PGE
  • Prostaglandins

Fingerprint

Dive into the research topics of 'Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow'. Together they form a unique fingerprint.

Cite this